{"entity":{"type":"insider","cik":"0001759855","url":"/insider/0001759855","json_url":"/insider/0001759855.json","name":"Parsons James T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2018-12-11","last":"2026-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Parsons James T.","source":"filing","n_filings":3,"first_seen":"2018-12-11","last_seen":"2026-03-13"}],"transactions":[{"id":6185729,"accession":"0001493152-26-009983","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-009983","line_url":"/filing/0001493152-26-009983#line-1","is_derivative":false,"issuer_cik":"0001129928","issuer_name":"ONCOLYTICS BIOTECH INC","issuer_ticker":"ONCY","issuer_name_source":null,"issuer_url":"/issuer/0001129928","owner_cik":"0001759855","owner_name":"Parsons James T.","owner_display_name":"Parsons James T.","owner_url":"/insider/0001759855","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":10300.0,"total_display":"10,300.00","total_whole":"10,300","shares_owned_after":41849.0,"shares_owned_after_display":"41,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":5042137,"accession":"0001062993-21-000293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000293","line_url":"/filing/0001062993-21-000293#line-2","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001759855","owner_name":"Parsons James T.","owner_display_name":"Parsons James T.","owner_url":"/insider/0001759855","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8505.0,"shares_display":"8,505","price_per_share":15.7873,"price_display":"15.79","price_state":"stated","total_value":134270.9865,"total_display":"134,270.99","total_whole":"134,271","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":6837198,"accession":"0001235802-18-000181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-18-000181","line_url":"/filing/0001235802-18-000181#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001759855","owner_name":"Parsons James T.","owner_display_name":"Parsons James T.","owner_url":"/insider/0001759855","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":6100.0,"shares_owned_after_display":"6,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001129928","name":"ONCOLYTICS BIOTECH INC","url":"/issuer/0001129928","role":"Director","n_filings":1,"first_seen":"2026-03-13","last_seen":"2026-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001616212","name":"Trillium Therapeutics Inc.","url":"/issuer/0001616212","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2021-01-12","last_seen":"2021-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001401040","name":"DiaMedica Therapeutics Inc.","url":"/issuer/0001401040","role":"Director","n_filings":1,"first_seen":"2018-12-11","last_seen":"2018-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001759855","retrieved_at":"2026-08-22T22:29:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}